Cornerstone Therapeutics Completes Acquisition of EKR Therapeutics
(Cary, N.C.) Cornerstone Therapeutics Inc. (NASDAQ: CRTX) has announced the closing of its acquisition of EKR Therapeutics, Inc., a privately-held specialty pharmaceutical company focused on the acute-care hospital setting. Pursuant to the merger agreement, EKR Therapeutics will become a wholly owned subsidiary of Cornerstone. (more…)
